Home › JMP Securities Upgrades BioCryst Pharmaceuticals to Outperform
 

Keywords :   


JMP Securities Upgrades BioCryst Pharmaceuticals to Outperform

2013-07-21 14:54:31| Biotech - Topix.net

The firm currently has a $3.00 price objective on the stock. JMP Securities' price target would indicate a potential upside of 21.95% from the stock's previous close.

Tags: securities upgrades pharmaceuticals outperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
More »